DK0473671T3 - Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel - Google Patents

Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel

Info

Publication number
DK0473671T3
DK0473671T3 DK90908385.9T DK90908385T DK0473671T3 DK 0473671 T3 DK0473671 T3 DK 0473671T3 DK 90908385 T DK90908385 T DK 90908385T DK 0473671 T3 DK0473671 T3 DK 0473671T3
Authority
DK
Denmark
Prior art keywords
prepare
sigma receptor
receptor ligands
anxiolytic agent
anxiolytic
Prior art date
Application number
DK90908385.9T
Other languages
English (en)
Inventor
Eckard Weber
John F W Keana
Original Assignee
Oregon State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon State filed Critical Oregon State
Application granted granted Critical
Publication of DK0473671T3 publication Critical patent/DK0473671T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DK90908385.9T 1989-05-02 1990-05-02 Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel DK0473671T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34649489A 1989-05-02 1989-05-02

Publications (1)

Publication Number Publication Date
DK0473671T3 true DK0473671T3 (da) 1994-09-19

Family

ID=23359655

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90908385.9T DK0473671T3 (da) 1989-05-02 1990-05-02 Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel

Country Status (9)

Country Link
EP (1) EP0473671B1 (da)
JP (1) JPH05500798A (da)
AT (1) ATE110265T1 (da)
AU (1) AU642881B2 (da)
CA (1) CA2054211A1 (da)
DE (1) DE69011859T2 (da)
DK (1) DK0473671T3 (da)
ES (1) ES2057568T3 (da)
WO (1) WO1990014067A2 (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385946A (en) * 1986-07-10 1995-01-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Method for treating hypertension with disubstituted granidine compounds
US5312840A (en) * 1986-07-10 1994-05-17 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education Substituted guanidines having high binding to the sigma receptor and the use thereof
US5262568A (en) * 1990-03-02 1993-11-16 State Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
JP3298875B2 (ja) 1990-03-02 2002-07-08 オレゴン州 三置換―および四置換グアニジン類およびそれらの興奮性アミノ酸アンタゴニストとしての用途
US5574070A (en) * 1990-05-25 1996-11-12 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Substituted guanidines having high binding to the sigma receptor and the use thereof
US5847006A (en) * 1991-02-08 1998-12-08 Cambridge Neuroscience, Inc. Therapeutic guanidines
DE69233479T2 (de) * 1991-02-08 2006-03-16 Scion Pharmaceuticals, Inc., Medford Substituierte Guanidine und Derivate hiervon als Modulatoren der Freisetzung von Neurotransmittern und neue Methode zur Identifizierung von Inhibitoren der Neurotransmitter-Freisetzung
US5741661A (en) * 1991-02-08 1998-04-21 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
DK78692D0 (da) * 1992-06-12 1992-06-12 Lundbeck & Co As H Dimere piperidin- og piperazinderivater
DK0705100T3 (da) * 1993-05-27 2003-11-17 Cenes Ltd Terapeutiske substituerede guanidiner
CA2177084A1 (en) * 1993-11-22 1995-06-01 Sharad Magar Therapeutic guanidines
KR100424523B1 (ko) * 1993-11-23 2004-09-30 캠브리지 뉴로사이언스, 인코포레이티드 치료용의치환된구아니딘
US6787569B1 (en) 1994-02-03 2004-09-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6143791A (en) * 1994-02-03 2000-11-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
KR100423272B1 (ko) 1994-02-03 2004-09-01 캠브리지 뉴로사이언스, 인코포레이티드 신경전달물질의방출을조절하는화합물,이의약학적으로허용가능한염및이를포함하는약학조성물
US7351743B1 (en) 1994-02-03 2008-04-01 Wyeth Therapeutic guanidines
WO1995023132A1 (en) * 1994-02-23 1995-08-31 Cambridge Neuroscience, Inc. Blockers of ion channels and methods of use thereof
US6756389B2 (en) 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US6875759B1 (en) 1999-07-21 2005-04-05 Kadmus Pharmaceuticals Substituted guanidines and the use thereof
EP1749824A1 (en) 2005-08-03 2007-02-07 Neuro3D Benzodiazepine derivatives, their preparation and the therapeutic use thereof
US9296697B2 (en) 2005-08-24 2016-03-29 Abbott Laboratories Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-HT5-receptors
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US9388126B2 (en) * 2012-07-19 2016-07-12 Drexel University Sigma receptor ligands and methods of modulating cellular protein homeostasis using same
WO2019089902A1 (en) 2017-11-01 2019-05-09 Drexel University Compounds, compositions, and methods for treating diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4709094A (en) * 1986-07-10 1987-11-24 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Sigma brain receptor ligands and their use

Also Published As

Publication number Publication date
WO1990014067A3 (en) 1991-04-04
EP0473671A1 (en) 1992-03-11
AU642881B2 (en) 1993-11-04
CA2054211A1 (en) 1990-11-03
DE69011859D1 (de) 1994-09-29
ATE110265T1 (de) 1994-09-15
JPH05500798A (ja) 1993-02-18
DE69011859T2 (de) 1994-12-15
EP0473671A4 (en) 1992-04-01
ES2057568T3 (es) 1994-10-16
EP0473671B1 (en) 1994-08-24
AU5728790A (en) 1990-12-18
WO1990014067A2 (en) 1990-11-29

Similar Documents

Publication Publication Date Title
DK0473671T3 (da) Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel
ATE174330T1 (de) Herbizide, substituierte aryl-haloalkylpyrazole
BR0012243A (pt) Triflúor butenos nematocidas
NO952494D0 (no) Nytt protein fra urin med betegnelse komponent B
ES2126122T3 (es) Nitrato-aminoacido-disulfuros para la terapia de enfermedades del sistema cardio-circulatorio.
LV10449A (lv) Jauni hromana un tiohromana atvasinajumi
ES521422A0 (es) Procedimiento para la obtencion de derivados de carboxilamida n-glicosilados.
DK0415613T3 (da) Anvendelse af sertralin til behandling af præmatur ejakulation
ES2059121T3 (es) Uso de agentes sensibilizantes de insulina para tratar la hipertension.
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
DK261490D0 (da) New pharmaceutical compound
FI972703A0 (fi) Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia
FI910653A0 (fi) Synteettiset reseptorianalogit
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
DK0471718T3 (da) Paracetamolholdigt farmaceutisk præparat
ES2078289T3 (es) Agente para mejorar la recuperacion de anexinas.
SE8700156L (sv) Kosmetiska kompositioner med hudlugnande och hudgenerande effekt och forfarande for framstellning derav
DK0571457T3 (da) Iloprost med virkning overfor cerebral malaria.
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
DE69114707D1 (de) Neue alpha-glukosidaseinhibitoren.
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
DE59008482D1 (de) Verfahren zur Herstellung von 2,4,5-Triamino-6-hydroxypyrimidin durch katalytische Hydrierung von 2,4-Diamino-6-hydroxy-5-nitrosopyrimidin.
ES2051953T3 (es) Derivados isomeros de trimetilbiciclo(4,3,0)nonano.
SE9501773D0 (sv) New use